Merck & Co to buy Schering-Plough in $41 billion deal
This article was originally published in Scrip
Executive Summary
Merck & Co is to buy Schering-Plough with a mix of cash and shares valued at $41.1 billion, the companies have announced. The deal comes over a month after another US firm, Pfizer, announced it was to buy Wyeth for $68 billion.